Patents by Inventor William E. Hapworth

William E. Hapworth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250262207
    Abstract: The present invention is directed to compositions containing a fatty acid amide hydrolase inhibitor and methods of use thereof for treatment of trauma-related psychiatric disorders in a patient in need thereof, particularly those that exhibiting hyperarousal symptomatology.
    Type: Application
    Filed: August 19, 2024
    Publication date: August 21, 2025
    Applicant: Neuritek Therapeutics Ltd.
    Inventors: William E. Hapworth, Alexander Neumeister
  • Publication number: 20250255866
    Abstract: The present invention is directed to compositions containing a fatty acid amide hydrolase inhibitor and methods of use thereof for treatment of trauma-related psychiatric disorders in a patient in need thereof, particularly those that exhibiting hyperarousal symptomatology.
    Type: Application
    Filed: April 4, 2025
    Publication date: August 14, 2025
    Applicant: Neuritek Therapeutics Ltd.
    Inventors: William E. Hapworth, Alexander Neumeister
  • Publication number: 20240180905
    Abstract: The present invention is directed to compositions containing a fatty acid amide hydrolase inhibitor and methods of use thereof for treatment of trauma-related psychiatric disorders in a patient in need thereof, particularly those that exhibiting hyperarousal symptomatology.
    Type: Application
    Filed: July 19, 2021
    Publication date: June 6, 2024
    Applicant: NEURITEK LTD.
    Inventors: William E. Hapworth, Alexander Neumeister
  • Patent number: 4940585
    Abstract: A therapeutic method for treatment of nicotine withdrawal syndrome symptoms of a patient in need thereof by administering to the patient a therapeutic composition of a pharmaceutically acceptable carrier and fluoxetine in an amount effective to provide physiological relief from the withdrawal symptoms.
    Type: Grant
    Filed: February 17, 1989
    Date of Patent: July 10, 1990
    Inventors: William E. Hapworth, Mada S. Hapworth